age-of-ai-europe-event-2026

Dr Dimitrios Kalogeropoulos

Chief Executive
Global Health & Digital Innovation Foundation & DorothAI

Dr Dimitrios Kalogeropoulos

Chief Executive
Global Health & Digital Innovation Foundation & DorothAI
Age of AI Europe 2026

Dr Dimitrios Kalogeropoulos is an internationally recognised leader in digital health, artificial intelligence, and health system governance, with over 30 years of experience shaping policy, regulation, and large-scale transformation across global health systems. He has advised the World Health Organization, the World Bank, and European institutions on translating data and AI into operational, governed, and scalable health system capabilities. His early work in systems medicine anticipated many of the challenges now defining Agentic AI in health. The architectural principles from this work prefigure today’s agentic and adaptive AI paradigms. This foundation is now being advanced through ASCEND, a global systems oncology initiative applying adaptive, safety-focused machine learning to real-world cancer care. Dr Kalogeropoulos is actively engaged in European and global policy processes, including participation in the EU AI Office Plenary, contributing to the operationalisation of the EU AI Act, the General-Purpose AI Code of Practice, and emerging transparency frameworks for AI-generated content. He also leads several standards and consensus-building efforts, including senior roles within IEEE, aligning innovation with regulation and public trust, and advises WHO and its volunteer knowledge communities on AI governance in health and public health. He holds a PhD in Artificial Intelligence in Medicine and is Chief Executive of the Global Health & Digital Innovation Foundation, and founder of DorothAI™, a platform advancing agentic AI through structured training, governance, and deployment pathways. His work is driven by the urgency to anchor AI governance in meaningful community engagement, transparency, collaboration and accountability.

Speaker's program:

10:50

-

11:30

A Real Debate on What’s Coming Next: Ethics, Regulation & the EU AI Act

  • The EU’s AI Act will reshape how pharma markets, personalises, and measures. This panel explore pharma frameworks, and how to stay compliant without holding back innovation.

Outcome: Leave a strong understanding of how AI solutions may violate the EU AI Act. Critical for those tasked with rolling out global initiatives in EU markets.

Pav Rishiraj
,
Director, Head of Pharmacovigilance & UK QPPV
,
IPSEN & ABPI Chair of Pharma Convigilance
Jasmine Agyekum,
,
Senior Associate
,
Clifford Chance
Dr Dimitrios Kalogeropoulos
,
Chief Executive
,
Global Health & Digital Innovation Foundation & DorothAI
Amman Ayub
,
Lead Counsel, UK & Ireland
,
Advanz Pharma

Join us November 26,  Toronto

REGISTER NOW

Join us at Age of AI, Europe. March 10.

Register today final tickets remain

Join us at SFE Canada. Oct 2, Toronto.

Register now

Join us at Age of AI, Europe. March 4.

THIS EVENT IS NOW SOLD OUT

Join us at Age of AI, Canada. June 17, Toronto.

REGISTER NOW